Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
John Adam ZangerleSr. VP, Gen Counsel, and Sec | SterisSTE | Open-market sale10b5-1 plan | 06/15 | 06/16 | 1,419 sh | $209.28 | $296,968.32 | −3.9% |
SterisSTE | Open-market sale10b5-1 plan | 06/04–06/05 | 06/08 | 4,428 sh2 trades | $213.82avg. | $946,798.56 | −6.5% | |
Richard C. BreedenDirector | SterisSTE | Open-market sale | 06/02 | 06/04 | 1,481 sh | $209.51 | $310,284.31 | −3.7% |
Feldmann Cynthia L.Director | SterisSTE | Open-market sale | 03/05 | 03/06 | 3,098 sh | $237.21 | $734,876.58 | −81.5% |
SterisSTE | Open-market sale | 25/11/21 | 25/11/25 | 5,008 sh2 trades | $262.00avg. | $1,312,096 | −31.9% | |
SterisSTE | Open-market sale | 25/11/18 | 25/11/20 | 5,036 sh3 trades | $257.55avg. | $1,297,039.68 | −46.9% | |
John Adam ZangerleSr. VP, Gen Counsel, and Sec | SterisSTE | Open-market sale | 25/11/11 | 25/11/13 | 15,000 sh | $265.14 | $3,977,100 | −30.8% |
Daniel A. CarestioPresident and CEO | SterisSTE | Open-market sale10b5-1 plan | 25/10/06 | 25/10/08 | 159 sh | $241.82 | $38,449.38 | −0.3% |
Renato TamaroV.P. & Corporate Treasurer | SterisSTE | Open-market sale | 25/08/20 | 25/08/22 | 3,204 sh | $249.24 | $798,564.96 | −30.7% |
Feldmann Cynthia L.Director | SterisSTE | Open-market sale | 25/08/11 | 25/08/12 | 3,495 sh | $241.56 | $844,252.2 | −83.2% |
Mohsen SohiDirector | SterisSTE | Open-market sale | 25/08/11 | 25/08/12 | 4,110 sh | $241.96 | $994,455.6 | −15.5% |
Karen L. BurtonVp & Cao | SterisSTE | Open-market sale | 25/08/11 | 25/08/12 | 7,900 sh | $241.73 | $1,909,667 | −56.9% |
SterisSTE | Open-market sale10b5-1 plan | 25/06/13 | 25/06/17 | 1,978 sh2 trades | $241.45avg. | $477,581.18 | −5.5% | |
SterisSTE | Open-market sale10b5-1 plan | 25/06/05 | 25/06/06 | 17,626 sh3 trades | $242.56avg. | $4,275,338.34 | −25.5% | |
SterisSTE | Open-market sale | 25/05/20 | 25/05/22 | 12,828 sh2 trades | $250.08avg. | $3,208,025.82 | −53.0% | |
Cary L. MajorsSVP and President, Healthcare | SterisSTE | Open-market sale | 24/11/25 | 24/11/27 | 1,682 sh | $217.32 | $365,532.24 | −12.9% |
SterisSTE | Open-market sale10b5-1 plan | 24/09/13–24/09/16 | 24/09/17 | 23,332 sh5 trades | $244.93avg. | $5,714,642.92 | −35.2% | |
Michael J. TokichSr. Vice Pres., CFO | SterisSTE | Open-market sale10b5-1 plan | 24/09/10 | 24/09/12 | 23,332 sh | $247.00 | $5,763,004 | −35.2% |
Christopher S. HollandDirector | SterisSTE | Open-market sale | 24/08/08 | 24/08/12 | 473 sh | $239.68 | $113,368.64 | −44.8% |
Cary L. MajorsSVP and President, Healthcare | SterisSTE | Open-market sale | 24/06/05 | 24/06/07 | 4,932 sh | $229.63 | $1,132,535.16 | −27.4% |
